Literature DB >> 16716514

Modulation of brain apoptosis-related proteins by the opioid antagonist naltrexone in mice.

Estela P San-Emeterio1, María A Hurlé.   

Abstract

Neuronal loss by apoptosis has been implicated in some neural pathologic disorders. Increasing evidence suggests a neuroprotective effect for opioid antagonists, such as naloxone and naltrexone, in a variety of neural damage experimental models and in the clinic. The purpose of the present study was to analyse the effects of naltrexone on the expression levels of proteins regulating the extrinsic (FasL and Fas) and the mitochondrial (Bcl-2, Bcl-xL, Bad and Bax) apoptotic pathways, as well as the active fragment of the executioner caspase-3 in the mouse brain. Western blotting showed that a single injection of naltrexone (1 mg/kg) induced a down-regulation of the pro-apototic proteins Fas, FasL, Bad and Bax. Our results suggest that naltrexone provides neuronal protection against injuries activating either mitochondrial, or death receptor-apoptotic pathways.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16716514     DOI: 10.1016/j.neulet.2006.04.053

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  10 in total

Review 1.  Endogenous opiates and behavior: 2006.

Authors:  Richard J Bodnar
Journal:  Peptides       Date:  2007-09-11       Impact factor: 3.750

Review 2.  New daily persistent headache and potential new therapeutic agents.

Authors:  Shivang G Joshi; Paul G Mathew; Herbert G Markley
Journal:  Curr Neurol Neurosci Rep       Date:  2014-02       Impact factor: 5.081

Review 3.  Current research on opioid receptor function.

Authors:  Yuan Feng; Xiaozhou He; Yilin Yang; Dongman Chao; Lawrence H Lazarus; Ying Xia
Journal:  Curr Drug Targets       Date:  2012-02       Impact factor: 3.465

4.  Gestational naltrexone ameliorates fetal ethanol exposures enhancing effect on the postnatal behavioral and neural response to ethanol.

Authors:  Steven L Youngentob; Paul F Kent; Lisa M Youngentob
Journal:  Exp Biol Med (Maywood)       Date:  2012-10-08

5.  Fibromyalgia symptoms are reduced by low-dose naltrexone: a pilot study.

Authors:  Jarred Younger; Sean Mackey
Journal:  Pain Med       Date:  2009-04-22       Impact factor: 3.750

6.  Ischemic insults promote epigenetic reprogramming of mu opioid receptor expression in hippocampal neurons.

Authors:  Luigi Formisano; Kyung-Min Noh; Takahiro Miyawaki; Toshihiro Mashiko; Michael V L Bennett; R Suzanne Zukin
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-28       Impact factor: 11.205

7.  Naltrexone is neuroprotective against traumatic brain injury in mu opioid receptor knockout mice.

Authors:  Yu-Syuan Wang; Tsai-Wei Hung; Eun-Kyung Bae; Kuo-Jen Wu; Wei Hsieh; Seong-Jin Yu
Journal:  CNS Neurosci Ther       Date:  2021-05-21       Impact factor: 5.243

8.  Low-dose naltrexone for pruritus in systemic sclerosis.

Authors:  Tracy Frech; Kirsten Novak; Monica P Revelo; Maureen Murtaugh; Boaz Markewitz; Nathan Hatton; Mary Beth Scholand; Edward Frech; David Markewitz; Allen D Sawitzke
Journal:  Int J Rheumatol       Date:  2011-09-12

9.  Chronic methadone treatment and repeated withdrawal impair cognition and increase the expression of apoptosis-related proteins in mouse brain.

Authors:  Mónica Tramullas; Carmen Martínez-Cué; María A Hurlé
Journal:  Psychopharmacology (Berl)       Date:  2007-03-24       Impact factor: 4.415

10.  Prenatal alcohol exposure increases postnatal acceptability of nicotine odor and taste in adolescent rats.

Authors:  Nicole M Mantella; Steven L Youngentob
Journal:  PLoS One       Date:  2014-07-16       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.